nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—NOS3—Alzheimer's disease	0.189	0.436	CbGaD
Doxorubicin—NOS2—Alzheimer's disease	0.182	0.421	CbGaD
Doxorubicin—CYP2D6—Alzheimer's disease	0.0623	0.144	CbGaD
Doxorubicin—CYP2B6—Memantine—Alzheimer's disease	0.0518	0.275	CbGbCtD
Doxorubicin—CYP2D6—Rivastigmine—Alzheimer's disease	0.0361	0.192	CbGbCtD
Doxorubicin—CYP2D6—Donepezil—Alzheimer's disease	0.0288	0.153	CbGbCtD
Doxorubicin—CYP3A4—Rivastigmine—Alzheimer's disease	0.0229	0.122	CbGbCtD
Doxorubicin—CYP2D6—Galantamine—Alzheimer's disease	0.0186	0.0987	CbGbCtD
Doxorubicin—CYP3A4—Donepezil—Alzheimer's disease	0.0183	0.0974	CbGbCtD
Doxorubicin—CYP3A4—Galantamine—Alzheimer's disease	0.0118	0.0627	CbGbCtD
Doxorubicin—CBR3—embryo—Alzheimer's disease	0.00204	0.0307	CbGeAlD
Doxorubicin—NOS1—blood vessel—Alzheimer's disease	0.002	0.0301	CbGeAlD
Doxorubicin—ABCB8—forebrain—Alzheimer's disease	0.00187	0.0282	CbGeAlD
Doxorubicin—ABCB8—telencephalon—Alzheimer's disease	0.00172	0.0259	CbGeAlD
Doxorubicin—NOS3—blood vessel—Alzheimer's disease	0.00152	0.0229	CbGeAlD
Doxorubicin—AKR1A1—telencephalon—Alzheimer's disease	0.00128	0.0193	CbGeAlD
Doxorubicin—NDUFS7—forebrain—Alzheimer's disease	0.00127	0.019	CbGeAlD
Doxorubicin—NDUFS7—telencephalon—Alzheimer's disease	0.00116	0.0175	CbGeAlD
Doxorubicin—NOS1—forebrain—Alzheimer's disease	0.00106	0.0159	CbGeAlD
Doxorubicin—NDUFS2—forebrain—Alzheimer's disease	0.00105	0.0158	CbGeAlD
Doxorubicin—NDUFS3—forebrain—Alzheimer's disease	0.00104	0.0156	CbGeAlD
Doxorubicin—ABCB8—nervous system—Alzheimer's disease	0.00102	0.0153	CbGeAlD
Doxorubicin—DHCR7—forebrain—Alzheimer's disease	0.000984	0.0148	CbGeAlD
Doxorubicin—ABCB8—central nervous system—Alzheimer's disease	0.000979	0.0147	CbGeAlD
Doxorubicin—CBR3—nervous system—Alzheimer's disease	0.000979	0.0147	CbGeAlD
Doxorubicin—NOS1—telencephalon—Alzheimer's disease	0.00097	0.0146	CbGeAlD
Doxorubicin—NDUFS2—telencephalon—Alzheimer's disease	0.000964	0.0145	CbGeAlD
Doxorubicin—ABCB8—cerebellum—Alzheimer's disease	0.000957	0.0144	CbGeAlD
Doxorubicin—NDUFS3—telencephalon—Alzheimer's disease	0.000952	0.0143	CbGeAlD
Doxorubicin—CBR3—central nervous system—Alzheimer's disease	0.000943	0.0142	CbGeAlD
Doxorubicin—CBR3—cerebellum—Alzheimer's disease	0.000921	0.0139	CbGeAlD
Doxorubicin—DHCR7—telencephalon—Alzheimer's disease	0.000905	0.0136	CbGeAlD
Doxorubicin—YWHAG—forebrain—Alzheimer's disease	0.000903	0.0136	CbGeAlD
Doxorubicin—YWHAG—telencephalon—Alzheimer's disease	0.00083	0.0125	CbGeAlD
Doxorubicin—RALBP1—forebrain—Alzheimer's disease	0.000816	0.0123	CbGeAlD
Doxorubicin—NOS3—forebrain—Alzheimer's disease	0.000802	0.0121	CbGeAlD
Doxorubicin—ABCB8—brain—Alzheimer's disease	0.000777	0.0117	CbGeAlD
Doxorubicin—CBR1—forebrain—Alzheimer's disease	0.000761	0.0115	CbGeAlD
Doxorubicin—AKR1A1—nervous system—Alzheimer's disease	0.000756	0.0114	CbGeAlD
Doxorubicin—RALBP1—telencephalon—Alzheimer's disease	0.00075	0.0113	CbGeAlD
Doxorubicin—CBR3—brain—Alzheimer's disease	0.000748	0.0113	CbGeAlD
Doxorubicin—NOS3—telencephalon—Alzheimer's disease	0.000738	0.0111	CbGeAlD
Doxorubicin—AKR1A1—central nervous system—Alzheimer's disease	0.000728	0.0109	CbGeAlD
Doxorubicin—AKR1A1—cerebellum—Alzheimer's disease	0.000711	0.0107	CbGeAlD
Doxorubicin—CBR1—telencephalon—Alzheimer's disease	0.0007	0.0105	CbGeAlD
Doxorubicin—NDUFS7—nervous system—Alzheimer's disease	0.000687	0.0103	CbGeAlD
Doxorubicin—NDUFS7—central nervous system—Alzheimer's disease	0.000661	0.00995	CbGeAlD
Doxorubicin—NDUFS7—cerebellum—Alzheimer's disease	0.000646	0.00973	CbGeAlD
Doxorubicin—AURKA—nervous system—Alzheimer's disease	0.000639	0.00961	CbGeAlD
Doxorubicin—AURKA—central nervous system—Alzheimer's disease	0.000615	0.00925	CbGeAlD
Doxorubicin—NQO1—forebrain—Alzheimer's disease	0.00061	0.00918	CbGeAlD
Doxorubicin—AKR1A1—brain—Alzheimer's disease	0.000578	0.00869	CbGeAlD
Doxorubicin—NOS1—nervous system—Alzheimer's disease	0.000573	0.00862	CbGeAlD
Doxorubicin—NDUFS2—nervous system—Alzheimer's disease	0.000569	0.00856	CbGeAlD
Doxorubicin—NDUFS3—nervous system—Alzheimer's disease	0.000562	0.00846	CbGeAlD
Doxorubicin—NQO1—telencephalon—Alzheimer's disease	0.000561	0.00844	CbGeAlD
Doxorubicin—NOS1—central nervous system—Alzheimer's disease	0.000552	0.0083	CbGeAlD
Doxorubicin—NDUFS2—central nervous system—Alzheimer's disease	0.000548	0.00825	CbGeAlD
Doxorubicin—NDUFS3—central nervous system—Alzheimer's disease	0.000541	0.00814	CbGeAlD
Doxorubicin—NOS1—cerebellum—Alzheimer's disease	0.000539	0.00811	CbGeAlD
Doxorubicin—NDUFS2—cerebellum—Alzheimer's disease	0.000536	0.00806	CbGeAlD
Doxorubicin—DHCR7—nervous system—Alzheimer's disease	0.000534	0.00804	CbGeAlD
Doxorubicin—NDUFS3—cerebellum—Alzheimer's disease	0.000529	0.00796	CbGeAlD
Doxorubicin—NDUFS7—brain—Alzheimer's disease	0.000525	0.0079	CbGeAlD
Doxorubicin—DHCR7—central nervous system—Alzheimer's disease	0.000514	0.00774	CbGeAlD
Doxorubicin—DHCR7—cerebellum—Alzheimer's disease	0.000503	0.00756	CbGeAlD
Doxorubicin—ABCC10—telencephalon—Alzheimer's disease	0.000501	0.00754	CbGeAlD
Doxorubicin—YWHAG—nervous system—Alzheimer's disease	0.00049	0.00737	CbGeAlD
Doxorubicin—AURKA—brain—Alzheimer's disease	0.000488	0.00734	CbGeAlD
Doxorubicin—YWHAG—central nervous system—Alzheimer's disease	0.000472	0.0071	CbGeAlD
Doxorubicin—YWHAG—cerebellum—Alzheimer's disease	0.000461	0.00694	CbGeAlD
Doxorubicin—RALBP1—nervous system—Alzheimer's disease	0.000443	0.00666	CbGeAlD
Doxorubicin—NOS1—brain—Alzheimer's disease	0.000438	0.00659	CbGeAlD
Doxorubicin—NOS3—nervous system—Alzheimer's disease	0.000436	0.00655	CbGeAlD
Doxorubicin—NDUFS2—brain—Alzheimer's disease	0.000435	0.00655	CbGeAlD
Doxorubicin—NDUFS3—brain—Alzheimer's disease	0.00043	0.00647	CbGeAlD
Doxorubicin—RALBP1—central nervous system—Alzheimer's disease	0.000426	0.00641	CbGeAlD
Doxorubicin—NOS3—central nervous system—Alzheimer's disease	0.000419	0.00631	CbGeAlD
Doxorubicin—RALBP1—cerebellum—Alzheimer's disease	0.000417	0.00627	CbGeAlD
Doxorubicin—CBR1—nervous system—Alzheimer's disease	0.000413	0.00622	CbGeAlD
Doxorubicin—DHCR7—brain—Alzheimer's disease	0.000408	0.00614	CbGeAlD
Doxorubicin—CBR1—central nervous system—Alzheimer's disease	0.000398	0.00599	CbGeAlD
Doxorubicin—CYP1B1—telencephalon—Alzheimer's disease	0.000394	0.00593	CbGeAlD
Doxorubicin—CBR1—cerebellum—Alzheimer's disease	0.000389	0.00585	CbGeAlD
Doxorubicin—AKR1C3—cerebellum—Alzheimer's disease	0.000384	0.00578	CbGeAlD
Doxorubicin—YWHAG—brain—Alzheimer's disease	0.000375	0.00564	CbGeAlD
Doxorubicin—ABCC1—telencephalon—Alzheimer's disease	0.000354	0.00533	CbGeAlD
Doxorubicin—POR—cerebellum—Alzheimer's disease	0.000351	0.00528	CbGeAlD
Doxorubicin—Idarubicin—CYP2D6—Alzheimer's disease	0.000348	1	CrCbGaD
Doxorubicin—RALBP1—brain—Alzheimer's disease	0.000338	0.00509	CbGeAlD
Doxorubicin—NOS3—brain—Alzheimer's disease	0.000333	0.00501	CbGeAlD
Doxorubicin—NQO1—nervous system—Alzheimer's disease	0.000331	0.00498	CbGeAlD
Doxorubicin—NQO1—central nervous system—Alzheimer's disease	0.000319	0.0048	CbGeAlD
Doxorubicin—CBR1—brain—Alzheimer's disease	0.000316	0.00475	CbGeAlD
Doxorubicin—AKR1C3—brain—Alzheimer's disease	0.000312	0.00469	CbGeAlD
Doxorubicin—NQO1—cerebellum—Alzheimer's disease	0.000312	0.00469	CbGeAlD
Doxorubicin—ABCB1—blood vessel—Alzheimer's disease	0.000298	0.00449	CbGeAlD
Doxorubicin—ABCC3—nervous system—Alzheimer's disease	0.000297	0.00447	CbGeAlD
Doxorubicin—ABCG2—telencephalon—Alzheimer's disease	0.000293	0.00441	CbGeAlD
Doxorubicin—ABCC3—central nervous system—Alzheimer's disease	0.000286	0.0043	CbGeAlD
Doxorubicin—POR—brain—Alzheimer's disease	0.000285	0.00429	CbGeAlD
Doxorubicin—ABCC10—cerebellum—Alzheimer's disease	0.000278	0.00419	CbGeAlD
Doxorubicin—NQO1—brain—Alzheimer's disease	0.000253	0.00381	CbGeAlD
Doxorubicin—CYP1B1—nervous system—Alzheimer's disease	0.000233	0.0035	CbGeAlD
Doxorubicin—ABCC3—brain—Alzheimer's disease	0.000227	0.00342	CbGeAlD
Doxorubicin—ABCC10—brain—Alzheimer's disease	0.000226	0.0034	CbGeAlD
Doxorubicin—CYP1B1—central nervous system—Alzheimer's disease	0.000224	0.00337	CbGeAlD
Doxorubicin—CYP1B1—cerebellum—Alzheimer's disease	0.000219	0.00329	CbGeAlD
Doxorubicin—CYP2D6—forebrain—Alzheimer's disease	0.000219	0.00329	CbGeAlD
Doxorubicin—CYP2D6—telencephalon—Alzheimer's disease	0.000201	0.00302	CbGeAlD
Doxorubicin—ABCC1—cerebellum—Alzheimer's disease	0.000197	0.00296	CbGeAlD
Doxorubicin—ABCB1—embryo—Alzheimer's disease	0.000178	0.00268	CbGeAlD
Doxorubicin—CYP1B1—brain—Alzheimer's disease	0.000178	0.00267	CbGeAlD
Doxorubicin—ABCG2—cerebellum—Alzheimer's disease	0.000163	0.00245	CbGeAlD
Doxorubicin—ABCC1—brain—Alzheimer's disease	0.00016	0.00241	CbGeAlD
Doxorubicin—CYP2B6—nervous system—Alzheimer's disease	0.00016	0.0024	CbGeAlD
Doxorubicin—ABCB1—forebrain—Alzheimer's disease	0.000157	0.00237	CbGeAlD
Doxorubicin—CYP2B6—central nervous system—Alzheimer's disease	0.000154	0.00231	CbGeAlD
Doxorubicin—ABCB1—telencephalon—Alzheimer's disease	0.000145	0.00218	CbGeAlD
Doxorubicin—ABCG2—brain—Alzheimer's disease	0.000132	0.00199	CbGeAlD
Doxorubicin—Connective tissue disorder—Memantine—Alzheimer's disease	0.00013	0.000704	CcSEcCtD
Doxorubicin—Rhinitis—Rivastigmine—Alzheimer's disease	0.000129	0.000702	CcSEcCtD
Doxorubicin—Skin disorder—Galantamine—Alzheimer's disease	0.000129	0.000702	CcSEcCtD
Doxorubicin—Urethral disorder—Memantine—Alzheimer's disease	0.000129	0.000702	CcSEcCtD
Doxorubicin—Hepatitis—Rivastigmine—Alzheimer's disease	0.000129	0.000701	CcSEcCtD
Doxorubicin—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000129	0.000701	CcSEcCtD
Doxorubicin—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000129	0.000699	CcSEcCtD
Doxorubicin—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000128	0.000697	CcSEcCtD
Doxorubicin—Alopecia—Donepezil—Alzheimer's disease	0.000128	0.000697	CcSEcCtD
Doxorubicin—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000128	0.000695	CcSEcCtD
Doxorubicin—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000127	0.000692	CcSEcCtD
Doxorubicin—Mental disorder—Donepezil—Alzheimer's disease	0.000127	0.000691	CcSEcCtD
Doxorubicin—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000127	0.00069	CcSEcCtD
Doxorubicin—Visual impairment—Memantine—Alzheimer's disease	0.000127	0.00069	CcSEcCtD
Doxorubicin—Anorexia—Galantamine—Alzheimer's disease	0.000127	0.000689	CcSEcCtD
Doxorubicin—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000127	0.000689	CcSEcCtD
Doxorubicin—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000127	0.000687	CcSEcCtD
Doxorubicin—Erythema—Donepezil—Alzheimer's disease	0.000126	0.000687	CcSEcCtD
Doxorubicin—Malnutrition—Donepezil—Alzheimer's disease	0.000126	0.000687	CcSEcCtD
Doxorubicin—Erythema multiforme—Memantine—Alzheimer's disease	0.000125	0.000677	CcSEcCtD
Doxorubicin—Flatulence—Donepezil—Alzheimer's disease	0.000125	0.000677	CcSEcCtD
Doxorubicin—Hypotension—Galantamine—Alzheimer's disease	0.000124	0.000676	CcSEcCtD
Doxorubicin—Visual impairment—Rivastigmine—Alzheimer's disease	0.000124	0.000675	CcSEcCtD
Doxorubicin—Tension—Donepezil—Alzheimer's disease	0.000124	0.000674	CcSEcCtD
Doxorubicin—Dysgeusia—Donepezil—Alzheimer's disease	0.000124	0.000672	CcSEcCtD
Doxorubicin—Eye disorder—Memantine—Alzheimer's disease	0.000123	0.000669	CcSEcCtD
Doxorubicin—Tinnitus—Memantine—Alzheimer's disease	0.000123	0.000668	CcSEcCtD
Doxorubicin—Nervousness—Donepezil—Alzheimer's disease	0.000123	0.000667	CcSEcCtD
Doxorubicin—Flushing—Memantine—Alzheimer's disease	0.000122	0.000665	CcSEcCtD
Doxorubicin—Cardiac disorder—Memantine—Alzheimer's disease	0.000122	0.000665	CcSEcCtD
Doxorubicin—Back pain—Donepezil—Alzheimer's disease	0.000122	0.000664	CcSEcCtD
Doxorubicin—CYP2B6—brain—Alzheimer's disease	0.000122	0.00184	CbGeAlD
Doxorubicin—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000122	0.000663	CcSEcCtD
Doxorubicin—Muscle spasms—Donepezil—Alzheimer's disease	0.000122	0.00066	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000121	0.000659	CcSEcCtD
Doxorubicin—CYP3A4—nervous system—Alzheimer's disease	0.000121	0.00181	CbGeAlD
Doxorubicin—Eye disorder—Rivastigmine—Alzheimer's disease	0.000121	0.000655	CcSEcCtD
Doxorubicin—Insomnia—Galantamine—Alzheimer's disease	0.00012	0.000654	CcSEcCtD
Doxorubicin—Tinnitus—Rivastigmine—Alzheimer's disease	0.00012	0.000653	CcSEcCtD
Doxorubicin—Flushing—Rivastigmine—Alzheimer's disease	0.00012	0.00065	CcSEcCtD
Doxorubicin—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00012	0.00065	CcSEcCtD
Doxorubicin—Angiopathy—Memantine—Alzheimer's disease	0.00012	0.00065	CcSEcCtD
Doxorubicin—Paraesthesia—Galantamine—Alzheimer's disease	0.00012	0.000649	CcSEcCtD
Doxorubicin—Vision blurred—Donepezil—Alzheimer's disease	0.000119	0.000647	CcSEcCtD
Doxorubicin—Immune system disorder—Memantine—Alzheimer's disease	0.000119	0.000647	CcSEcCtD
Doxorubicin—Mediastinal disorder—Memantine—Alzheimer's disease	0.000119	0.000646	CcSEcCtD
Doxorubicin—CYP2D6—nervous system—Alzheimer's disease	0.000119	0.00179	CbGeAlD
Doxorubicin—Somnolence—Galantamine—Alzheimer's disease	0.000118	0.000643	CcSEcCtD
Doxorubicin—Chills—Memantine—Alzheimer's disease	0.000118	0.000643	CcSEcCtD
Doxorubicin—Arrhythmia—Memantine—Alzheimer's disease	0.000118	0.00064	CcSEcCtD
Doxorubicin—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000117	0.000637	CcSEcCtD
Doxorubicin—Dyspepsia—Galantamine—Alzheimer's disease	0.000117	0.000637	CcSEcCtD
Doxorubicin—Angiopathy—Rivastigmine—Alzheimer's disease	0.000117	0.000636	CcSEcCtD
Doxorubicin—Anaemia—Donepezil—Alzheimer's disease	0.000117	0.000635	CcSEcCtD
Doxorubicin—Alopecia—Memantine—Alzheimer's disease	0.000117	0.000633	CcSEcCtD
Doxorubicin—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000116	0.000632	CcSEcCtD
Doxorubicin—Agitation—Donepezil—Alzheimer's disease	0.000116	0.000631	CcSEcCtD
Doxorubicin—CYP3A4—central nervous system—Alzheimer's disease	0.000116	0.00175	CbGeAlD
Doxorubicin—Chills—Rivastigmine—Alzheimer's disease	0.000116	0.000629	CcSEcCtD
Doxorubicin—Decreased appetite—Galantamine—Alzheimer's disease	0.000116	0.000629	CcSEcCtD
Doxorubicin—Mental disorder—Memantine—Alzheimer's disease	0.000116	0.000628	CcSEcCtD
Doxorubicin—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000115	0.000626	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000115	0.000624	CcSEcCtD
Doxorubicin—Malnutrition—Memantine—Alzheimer's disease	0.000115	0.000624	CcSEcCtD
Doxorubicin—Fatigue—Galantamine—Alzheimer's disease	0.000115	0.000623	CcSEcCtD
Doxorubicin—CYP2D6—central nervous system—Alzheimer's disease	0.000114	0.00172	CbGeAlD
Doxorubicin—Malaise—Donepezil—Alzheimer's disease	0.000114	0.000619	CcSEcCtD
Doxorubicin—Alopecia—Rivastigmine—Alzheimer's disease	0.000114	0.000619	CcSEcCtD
Doxorubicin—Constipation—Galantamine—Alzheimer's disease	0.000114	0.000618	CcSEcCtD
Doxorubicin—Vertigo—Donepezil—Alzheimer's disease	0.000114	0.000617	CcSEcCtD
Doxorubicin—Syncope—Donepezil—Alzheimer's disease	0.000113	0.000616	CcSEcCtD
Doxorubicin—Flatulence—Memantine—Alzheimer's disease	0.000113	0.000614	CcSEcCtD
Doxorubicin—Mental disorder—Rivastigmine—Alzheimer's disease	0.000113	0.000614	CcSEcCtD
Doxorubicin—Tension—Memantine—Alzheimer's disease	0.000113	0.000612	CcSEcCtD
Doxorubicin—Dysgeusia—Memantine—Alzheimer's disease	0.000112	0.000611	CcSEcCtD
Doxorubicin—Erythema—Rivastigmine—Alzheimer's disease	0.000112	0.00061	CcSEcCtD
Doxorubicin—Malnutrition—Rivastigmine—Alzheimer's disease	0.000112	0.00061	CcSEcCtD
Doxorubicin—CYP2D6—cerebellum—Alzheimer's disease	0.000112	0.00168	CbGeAlD
Doxorubicin—Nervousness—Memantine—Alzheimer's disease	0.000112	0.000606	CcSEcCtD
Doxorubicin—Loss of consciousness—Donepezil—Alzheimer's disease	0.000111	0.000604	CcSEcCtD
Doxorubicin—Back pain—Memantine—Alzheimer's disease	0.000111	0.000603	CcSEcCtD
Doxorubicin—Flatulence—Rivastigmine—Alzheimer's disease	0.000111	0.000601	CcSEcCtD
Doxorubicin—Cough—Donepezil—Alzheimer's disease	0.00011	0.000599	CcSEcCtD
Doxorubicin—Tension—Rivastigmine—Alzheimer's disease	0.00011	0.000599	CcSEcCtD
Doxorubicin—Dysgeusia—Rivastigmine—Alzheimer's disease	0.00011	0.000597	CcSEcCtD
Doxorubicin—Feeling abnormal—Galantamine—Alzheimer's disease	0.00011	0.000596	CcSEcCtD
Doxorubicin—Convulsion—Donepezil—Alzheimer's disease	0.00011	0.000595	CcSEcCtD
Doxorubicin—Hypertension—Donepezil—Alzheimer's disease	0.000109	0.000593	CcSEcCtD
Doxorubicin—Nervousness—Rivastigmine—Alzheimer's disease	0.000109	0.000592	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000109	0.000591	CcSEcCtD
Doxorubicin—Back pain—Rivastigmine—Alzheimer's disease	0.000109	0.00059	CcSEcCtD
Doxorubicin—Vision blurred—Memantine—Alzheimer's disease	0.000108	0.000588	CcSEcCtD
Doxorubicin—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000108	0.000586	CcSEcCtD
Doxorubicin—Chest pain—Donepezil—Alzheimer's disease	0.000108	0.000585	CcSEcCtD
Doxorubicin—Myalgia—Donepezil—Alzheimer's disease	0.000108	0.000585	CcSEcCtD
Doxorubicin—Arthralgia—Donepezil—Alzheimer's disease	0.000108	0.000585	CcSEcCtD
Doxorubicin—Anxiety—Donepezil—Alzheimer's disease	0.000107	0.000583	CcSEcCtD
Doxorubicin—Ill-defined disorder—Memantine—Alzheimer's disease	0.000107	0.000579	CcSEcCtD
Doxorubicin—Discomfort—Donepezil—Alzheimer's disease	0.000106	0.000578	CcSEcCtD
Doxorubicin—Anaemia—Memantine—Alzheimer's disease	0.000106	0.000576	CcSEcCtD
Doxorubicin—Vision blurred—Rivastigmine—Alzheimer's disease	0.000106	0.000575	CcSEcCtD
Doxorubicin—Agitation—Memantine—Alzheimer's disease	0.000106	0.000573	CcSEcCtD
Doxorubicin—Dry mouth—Donepezil—Alzheimer's disease	0.000105	0.000572	CcSEcCtD
Doxorubicin—Body temperature increased—Galantamine—Alzheimer's disease	0.000105	0.000572	CcSEcCtD
Doxorubicin—Abdominal pain—Galantamine—Alzheimer's disease	0.000105	0.000572	CcSEcCtD
Doxorubicin—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000104	0.000566	CcSEcCtD
Doxorubicin—Confusional state—Donepezil—Alzheimer's disease	0.000104	0.000565	CcSEcCtD
Doxorubicin—Anaemia—Rivastigmine—Alzheimer's disease	0.000104	0.000564	CcSEcCtD
Doxorubicin—Malaise—Memantine—Alzheimer's disease	0.000104	0.000562	CcSEcCtD
Doxorubicin—Agitation—Rivastigmine—Alzheimer's disease	0.000103	0.000561	CcSEcCtD
Doxorubicin—Oedema—Donepezil—Alzheimer's disease	0.000103	0.00056	CcSEcCtD
Doxorubicin—Vertigo—Memantine—Alzheimer's disease	0.000103	0.00056	CcSEcCtD
Doxorubicin—Syncope—Memantine—Alzheimer's disease	0.000103	0.000559	CcSEcCtD
Doxorubicin—Leukopenia—Memantine—Alzheimer's disease	0.000103	0.000558	CcSEcCtD
Doxorubicin—Infection—Donepezil—Alzheimer's disease	0.000103	0.000557	CcSEcCtD
Doxorubicin—Shock—Donepezil—Alzheimer's disease	0.000102	0.000551	CcSEcCtD
Doxorubicin—Palpitations—Memantine—Alzheimer's disease	0.000101	0.000551	CcSEcCtD
Doxorubicin—Malaise—Rivastigmine—Alzheimer's disease	0.000101	0.00055	CcSEcCtD
Doxorubicin—Nervous system disorder—Donepezil—Alzheimer's disease	0.000101	0.00055	CcSEcCtD
Doxorubicin—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000101	0.000549	CcSEcCtD
Doxorubicin—Vertigo—Rivastigmine—Alzheimer's disease	0.000101	0.000548	CcSEcCtD
Doxorubicin—Loss of consciousness—Memantine—Alzheimer's disease	0.000101	0.000548	CcSEcCtD
Doxorubicin—Syncope—Rivastigmine—Alzheimer's disease	0.000101	0.000547	CcSEcCtD
Doxorubicin—Cough—Memantine—Alzheimer's disease	0.0001	0.000544	CcSEcCtD
Doxorubicin—Hyperhidrosis—Donepezil—Alzheimer's disease	9.98e-05	0.000542	CcSEcCtD
Doxorubicin—Convulsion—Memantine—Alzheimer's disease	9.95e-05	0.00054	CcSEcCtD
Doxorubicin—Palpitations—Rivastigmine—Alzheimer's disease	9.93e-05	0.000539	CcSEcCtD
Doxorubicin—Hypertension—Memantine—Alzheimer's disease	9.92e-05	0.000538	CcSEcCtD
Doxorubicin—Loss of consciousness—Rivastigmine—Alzheimer's disease	9.88e-05	0.000536	CcSEcCtD
Doxorubicin—Anorexia—Donepezil—Alzheimer's disease	9.84e-05	0.000534	CcSEcCtD
Doxorubicin—Hypersensitivity—Galantamine—Alzheimer's disease	9.81e-05	0.000533	CcSEcCtD
Doxorubicin—Cough—Rivastigmine—Alzheimer's disease	9.8e-05	0.000532	CcSEcCtD
Doxorubicin—Chest pain—Memantine—Alzheimer's disease	9.78e-05	0.000531	CcSEcCtD
Doxorubicin—Myalgia—Memantine—Alzheimer's disease	9.78e-05	0.000531	CcSEcCtD
Doxorubicin—Arthralgia—Memantine—Alzheimer's disease	9.78e-05	0.000531	CcSEcCtD
Doxorubicin—Anxiety—Memantine—Alzheimer's disease	9.74e-05	0.000529	CcSEcCtD
Doxorubicin—Convulsion—Rivastigmine—Alzheimer's disease	9.73e-05	0.000528	CcSEcCtD
Doxorubicin—Hypertension—Rivastigmine—Alzheimer's disease	9.7e-05	0.000527	CcSEcCtD
Doxorubicin—Discomfort—Memantine—Alzheimer's disease	9.66e-05	0.000524	CcSEcCtD
Doxorubicin—Hypotension—Donepezil—Alzheimer's disease	9.65e-05	0.000524	CcSEcCtD
Doxorubicin—Myalgia—Rivastigmine—Alzheimer's disease	9.57e-05	0.000519	CcSEcCtD
Doxorubicin—Chest pain—Rivastigmine—Alzheimer's disease	9.57e-05	0.000519	CcSEcCtD
Doxorubicin—Arthralgia—Rivastigmine—Alzheimer's disease	9.57e-05	0.000519	CcSEcCtD
Doxorubicin—Dry mouth—Memantine—Alzheimer's disease	9.56e-05	0.000519	CcSEcCtD
Doxorubicin—Asthenia—Galantamine—Alzheimer's disease	9.56e-05	0.000519	CcSEcCtD
Doxorubicin—Anxiety—Rivastigmine—Alzheimer's disease	9.53e-05	0.000518	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	9.5e-05	0.000516	CcSEcCtD
Doxorubicin—Confusional state—Memantine—Alzheimer's disease	9.45e-05	0.000513	CcSEcCtD
Doxorubicin—Discomfort—Rivastigmine—Alzheimer's disease	9.45e-05	0.000513	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	9.41e-05	0.000511	CcSEcCtD
Doxorubicin—Oedema—Memantine—Alzheimer's disease	9.37e-05	0.000509	CcSEcCtD
Doxorubicin—Dry mouth—Rivastigmine—Alzheimer's disease	9.35e-05	0.000508	CcSEcCtD
Doxorubicin—Insomnia—Donepezil—Alzheimer's disease	9.34e-05	0.000507	CcSEcCtD
Doxorubicin—Infection—Memantine—Alzheimer's disease	9.31e-05	0.000506	CcSEcCtD
Doxorubicin—Paraesthesia—Donepezil—Alzheimer's disease	9.27e-05	0.000503	CcSEcCtD
Doxorubicin—Confusional state—Rivastigmine—Alzheimer's disease	9.25e-05	0.000502	CcSEcCtD
Doxorubicin—Shock—Memantine—Alzheimer's disease	9.22e-05	0.000501	CcSEcCtD
Doxorubicin—Dyspnoea—Donepezil—Alzheimer's disease	9.2e-05	0.0005	CcSEcCtD
Doxorubicin—Nervous system disorder—Memantine—Alzheimer's disease	9.19e-05	0.000499	CcSEcCtD
Doxorubicin—Somnolence—Donepezil—Alzheimer's disease	9.18e-05	0.000498	CcSEcCtD
Doxorubicin—Thrombocytopenia—Memantine—Alzheimer's disease	9.18e-05	0.000498	CcSEcCtD
Doxorubicin—Oedema—Rivastigmine—Alzheimer's disease	9.17e-05	0.000498	CcSEcCtD
Doxorubicin—Tachycardia—Memantine—Alzheimer's disease	9.15e-05	0.000497	CcSEcCtD
Doxorubicin—Diarrhoea—Galantamine—Alzheimer's disease	9.11e-05	0.000495	CcSEcCtD
Doxorubicin—Infection—Rivastigmine—Alzheimer's disease	9.11e-05	0.000495	CcSEcCtD
Doxorubicin—Skin disorder—Memantine—Alzheimer's disease	9.1e-05	0.000494	CcSEcCtD
Doxorubicin—Dyspepsia—Donepezil—Alzheimer's disease	9.09e-05	0.000493	CcSEcCtD
Doxorubicin—CYP2D6—brain—Alzheimer's disease	9.07e-05	0.00137	CbGeAlD
Doxorubicin—Hyperhidrosis—Memantine—Alzheimer's disease	9.06e-05	0.000492	CcSEcCtD
Doxorubicin—Shock—Rivastigmine—Alzheimer's disease	9.02e-05	0.00049	CcSEcCtD
Doxorubicin—Nervous system disorder—Rivastigmine—Alzheimer's disease	8.99e-05	0.000488	CcSEcCtD
Doxorubicin—Thrombocytopenia—Rivastigmine—Alzheimer's disease	8.98e-05	0.000487	CcSEcCtD
Doxorubicin—Decreased appetite—Donepezil—Alzheimer's disease	8.97e-05	0.000487	CcSEcCtD
Doxorubicin—Tachycardia—Rivastigmine—Alzheimer's disease	8.95e-05	0.000486	CcSEcCtD
Doxorubicin—Anorexia—Memantine—Alzheimer's disease	8.93e-05	0.000485	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Donepezil—Alzheimer's disease	8.91e-05	0.000484	CcSEcCtD
Doxorubicin—Skin disorder—Rivastigmine—Alzheimer's disease	8.91e-05	0.000484	CcSEcCtD
Doxorubicin—Fatigue—Donepezil—Alzheimer's disease	8.9e-05	0.000483	CcSEcCtD
Doxorubicin—Hyperhidrosis—Rivastigmine—Alzheimer's disease	8.86e-05	0.000481	CcSEcCtD
Doxorubicin—Pain—Donepezil—Alzheimer's disease	8.83e-05	0.000479	CcSEcCtD
Doxorubicin—Constipation—Donepezil—Alzheimer's disease	8.83e-05	0.000479	CcSEcCtD
Doxorubicin—Dizziness—Galantamine—Alzheimer's disease	8.81e-05	0.000478	CcSEcCtD
Doxorubicin—Hypotension—Memantine—Alzheimer's disease	8.76e-05	0.000476	CcSEcCtD
Doxorubicin—Anorexia—Rivastigmine—Alzheimer's disease	8.74e-05	0.000475	CcSEcCtD
Doxorubicin—Hypotension—Rivastigmine—Alzheimer's disease	8.57e-05	0.000465	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Memantine—Alzheimer's disease	8.54e-05	0.000464	CcSEcCtD
Doxorubicin—ABCB1—nervous system—Alzheimer's disease	8.54e-05	0.00128	CbGeAlD
Doxorubicin—Feeling abnormal—Donepezil—Alzheimer's disease	8.51e-05	0.000462	CcSEcCtD
Doxorubicin—Insomnia—Memantine—Alzheimer's disease	8.48e-05	0.00046	CcSEcCtD
Doxorubicin—Vomiting—Galantamine—Alzheimer's disease	8.47e-05	0.00046	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Donepezil—Alzheimer's disease	8.44e-05	0.000458	CcSEcCtD
Doxorubicin—Paraesthesia—Memantine—Alzheimer's disease	8.42e-05	0.000457	CcSEcCtD
Doxorubicin—Rash—Galantamine—Alzheimer's disease	8.4e-05	0.000456	CcSEcCtD
Doxorubicin—Dermatitis—Galantamine—Alzheimer's disease	8.39e-05	0.000456	CcSEcCtD
Doxorubicin—Dyspnoea—Memantine—Alzheimer's disease	8.36e-05	0.000454	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	8.35e-05	0.000454	CcSEcCtD
Doxorubicin—Headache—Galantamine—Alzheimer's disease	8.34e-05	0.000453	CcSEcCtD
Doxorubicin—Somnolence—Memantine—Alzheimer's disease	8.33e-05	0.000452	CcSEcCtD
Doxorubicin—Insomnia—Rivastigmine—Alzheimer's disease	8.29e-05	0.00045	CcSEcCtD
Doxorubicin—Dyspepsia—Memantine—Alzheimer's disease	8.25e-05	0.000448	CcSEcCtD
Doxorubicin—Paraesthesia—Rivastigmine—Alzheimer's disease	8.23e-05	0.000447	CcSEcCtD
Doxorubicin—ABCB1—central nervous system—Alzheimer's disease	8.22e-05	0.00124	CbGeAlD
Doxorubicin—Urticaria—Donepezil—Alzheimer's disease	8.2e-05	0.000445	CcSEcCtD
Doxorubicin—Dyspnoea—Rivastigmine—Alzheimer's disease	8.18e-05	0.000444	CcSEcCtD
Doxorubicin—Abdominal pain—Donepezil—Alzheimer's disease	8.16e-05	0.000443	CcSEcCtD
Doxorubicin—Body temperature increased—Donepezil—Alzheimer's disease	8.16e-05	0.000443	CcSEcCtD
Doxorubicin—Somnolence—Rivastigmine—Alzheimer's disease	8.15e-05	0.000443	CcSEcCtD
Doxorubicin—Decreased appetite—Memantine—Alzheimer's disease	8.15e-05	0.000442	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Memantine—Alzheimer's disease	8.09e-05	0.000439	CcSEcCtD
Doxorubicin—Fatigue—Memantine—Alzheimer's disease	8.08e-05	0.000439	CcSEcCtD
Doxorubicin—Dyspepsia—Rivastigmine—Alzheimer's disease	8.07e-05	0.000438	CcSEcCtD
Doxorubicin—ABCB1—cerebellum—Alzheimer's disease	8.04e-05	0.00121	CbGeAlD
Doxorubicin—Pain—Memantine—Alzheimer's disease	8.02e-05	0.000435	CcSEcCtD
Doxorubicin—Constipation—Memantine—Alzheimer's disease	8.02e-05	0.000435	CcSEcCtD
Doxorubicin—Decreased appetite—Rivastigmine—Alzheimer's disease	7.97e-05	0.000433	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	7.92e-05	0.00043	CcSEcCtD
Doxorubicin—Nausea—Galantamine—Alzheimer's disease	7.91e-05	0.00043	CcSEcCtD
Doxorubicin—Fatigue—Rivastigmine—Alzheimer's disease	7.91e-05	0.000429	CcSEcCtD
Doxorubicin—Pain—Rivastigmine—Alzheimer's disease	7.84e-05	0.000426	CcSEcCtD
Doxorubicin—Constipation—Rivastigmine—Alzheimer's disease	7.84e-05	0.000426	CcSEcCtD
Doxorubicin—Feeling abnormal—Memantine—Alzheimer's disease	7.72e-05	0.000419	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Memantine—Alzheimer's disease	7.66e-05	0.000416	CcSEcCtD
Doxorubicin—Hypersensitivity—Donepezil—Alzheimer's disease	7.61e-05	0.000413	CcSEcCtD
Doxorubicin—Feeling abnormal—Rivastigmine—Alzheimer's disease	7.56e-05	0.00041	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	7.5e-05	0.000407	CcSEcCtD
Doxorubicin—Urticaria—Memantine—Alzheimer's disease	7.45e-05	0.000404	CcSEcCtD
Doxorubicin—Abdominal pain—Memantine—Alzheimer's disease	7.41e-05	0.000402	CcSEcCtD
Doxorubicin—Body temperature increased—Memantine—Alzheimer's disease	7.41e-05	0.000402	CcSEcCtD
Doxorubicin—Asthenia—Donepezil—Alzheimer's disease	7.41e-05	0.000402	CcSEcCtD
Doxorubicin—Pruritus—Donepezil—Alzheimer's disease	7.3e-05	0.000397	CcSEcCtD
Doxorubicin—Urticaria—Rivastigmine—Alzheimer's disease	7.28e-05	0.000395	CcSEcCtD
Doxorubicin—Body temperature increased—Rivastigmine—Alzheimer's disease	7.25e-05	0.000394	CcSEcCtD
Doxorubicin—Abdominal pain—Rivastigmine—Alzheimer's disease	7.25e-05	0.000394	CcSEcCtD
Doxorubicin—Diarrhoea—Donepezil—Alzheimer's disease	7.06e-05	0.000383	CcSEcCtD
Doxorubicin—Hypersensitivity—Memantine—Alzheimer's disease	6.91e-05	0.000375	CcSEcCtD
Doxorubicin—Dizziness—Donepezil—Alzheimer's disease	6.83e-05	0.000371	CcSEcCtD
Doxorubicin—Hypersensitivity—Rivastigmine—Alzheimer's disease	6.76e-05	0.000367	CcSEcCtD
Doxorubicin—Asthenia—Memantine—Alzheimer's disease	6.73e-05	0.000365	CcSEcCtD
Doxorubicin—Pruritus—Memantine—Alzheimer's disease	6.63e-05	0.00036	CcSEcCtD
Doxorubicin—Asthenia—Rivastigmine—Alzheimer's disease	6.58e-05	0.000357	CcSEcCtD
Doxorubicin—Vomiting—Donepezil—Alzheimer's disease	6.56e-05	0.000356	CcSEcCtD
Doxorubicin—ABCB1—brain—Alzheimer's disease	6.53e-05	0.000982	CbGeAlD
Doxorubicin—Rash—Donepezil—Alzheimer's disease	6.51e-05	0.000353	CcSEcCtD
Doxorubicin—Dermatitis—Donepezil—Alzheimer's disease	6.5e-05	0.000353	CcSEcCtD
Doxorubicin—Pruritus—Rivastigmine—Alzheimer's disease	6.49e-05	0.000352	CcSEcCtD
Doxorubicin—Headache—Donepezil—Alzheimer's disease	6.47e-05	0.000351	CcSEcCtD
Doxorubicin—Diarrhoea—Memantine—Alzheimer's disease	6.41e-05	0.000348	CcSEcCtD
Doxorubicin—Diarrhoea—Rivastigmine—Alzheimer's disease	6.27e-05	0.000341	CcSEcCtD
Doxorubicin—Dizziness—Memantine—Alzheimer's disease	6.2e-05	0.000337	CcSEcCtD
Doxorubicin—Nausea—Donepezil—Alzheimer's disease	6.13e-05	0.000333	CcSEcCtD
Doxorubicin—Dizziness—Rivastigmine—Alzheimer's disease	6.06e-05	0.000329	CcSEcCtD
Doxorubicin—Vomiting—Memantine—Alzheimer's disease	5.96e-05	0.000324	CcSEcCtD
Doxorubicin—Rash—Memantine—Alzheimer's disease	5.91e-05	0.000321	CcSEcCtD
Doxorubicin—Dermatitis—Memantine—Alzheimer's disease	5.9e-05	0.000321	CcSEcCtD
Doxorubicin—Headache—Memantine—Alzheimer's disease	5.87e-05	0.000319	CcSEcCtD
Doxorubicin—Vomiting—Rivastigmine—Alzheimer's disease	5.83e-05	0.000317	CcSEcCtD
Doxorubicin—Rash—Rivastigmine—Alzheimer's disease	5.78e-05	0.000314	CcSEcCtD
Doxorubicin—Dermatitis—Rivastigmine—Alzheimer's disease	5.78e-05	0.000314	CcSEcCtD
Doxorubicin—Headache—Rivastigmine—Alzheimer's disease	5.74e-05	0.000312	CcSEcCtD
Doxorubicin—Nausea—Memantine—Alzheimer's disease	5.57e-05	0.000302	CcSEcCtD
Doxorubicin—Nausea—Rivastigmine—Alzheimer's disease	5.45e-05	0.000296	CcSEcCtD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.46e-06	3.5e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CA4—Alzheimer's disease	4.42e-06	3.47e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HTR2A—Alzheimer's disease	4.42e-06	3.47e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ABCA1—Alzheimer's disease	4.4e-06	3.46e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GAPDH—Alzheimer's disease	4.39e-06	3.44e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—BCHE—Alzheimer's disease	4.38e-06	3.44e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—NOS3—Alzheimer's disease	4.36e-06	3.42e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TGFB1—Alzheimer's disease	4.35e-06	3.41e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—MTHFR—Alzheimer's disease	4.28e-06	3.36e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PPARG—Alzheimer's disease	4.28e-06	3.36e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—LPL—Alzheimer's disease	4.26e-06	3.35e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—A2M—Alzheimer's disease	4.24e-06	3.32e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—GSK3B—Alzheimer's disease	4.21e-06	3.31e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—INS—Alzheimer's disease	4.2e-06	3.29e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CREB1—Alzheimer's disease	4.18e-06	3.28e-05	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—AKT1—Alzheimer's disease	4.17e-06	3.28e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	4.16e-06	3.26e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—INS—Alzheimer's disease	4.15e-06	3.26e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PRKCG—Alzheimer's disease	4.15e-06	3.25e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	4.13e-06	3.24e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PLCB1—Alzheimer's disease	4.13e-06	3.24e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PTGS2—Alzheimer's disease	4.13e-06	3.24e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CALM1—Alzheimer's disease	4.12e-06	3.24e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—LEP—Alzheimer's disease	4.11e-06	3.22e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—APOE—Alzheimer's disease	4.11e-06	3.22e-05	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—TP53—Alzheimer's disease	4.11e-06	3.22e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—MTHFR—Alzheimer's disease	4.1e-06	3.22e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCL2—Alzheimer's disease	4.09e-06	3.21e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CAV1—Alzheimer's disease	4.07e-06	3.19e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—NOS3—Alzheimer's disease	4.05e-06	3.18e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PTGS2—Alzheimer's disease	4.02e-06	3.16e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IGF1—Alzheimer's disease	4.02e-06	3.15e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ABCA1—Alzheimer's disease	4.01e-06	3.14e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—CALM1—Alzheimer's disease	4e-06	3.14e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—APOE—Alzheimer's disease	3.99e-06	3.13e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PTGS2—Alzheimer's disease	3.98e-06	3.13e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	3.97e-06	3.11e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—CAV1—Alzheimer's disease	3.95e-06	3.1e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	3.94e-06	3.09e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CCR5—Alzheimer's disease	3.93e-06	3.08e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PPARGC1A—Alzheimer's disease	3.92e-06	3.08e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—ESR1—Alzheimer's disease	3.92e-06	3.08e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—HMOX1—Alzheimer's disease	3.91e-06	3.07e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—F2—Alzheimer's disease	3.87e-06	3.04e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MTHFR—Alzheimer's disease	3.84e-06	3.01e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—CALM1—Alzheimer's disease	3.83e-06	3.01e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—APOE—Alzheimer's disease	3.82e-06	3e-05	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—AKT1—Alzheimer's disease	3.81e-06	2.99e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PPARGC1A—Alzheimer's disease	3.79e-06	2.98e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	3.79e-06	2.98e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—NOTCH1—Alzheimer's disease	3.79e-06	2.98e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—CAV1—Alzheimer's disease	3.79e-06	2.97e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—HMOX1—Alzheimer's disease	3.78e-06	2.96e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PLD3—Alzheimer's disease	3.76e-06	2.95e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—TGFB1—Alzheimer's disease	3.74e-06	2.94e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—IL6—Alzheimer's disease	3.74e-06	2.94e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PTGS2—Alzheimer's disease	3.7e-06	2.91e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ACHE—Alzheimer's disease	3.68e-06	2.89e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NOS3—Alzheimer's disease	3.64e-06	2.86e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—INPP5D—Alzheimer's disease	3.64e-06	2.86e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	3.6e-06	2.83e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CALM1—Alzheimer's disease	3.59e-06	2.82e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TP53—Alzheimer's disease	3.58e-06	2.81e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—APOE—Alzheimer's disease	3.57e-06	2.81e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—LPL—Alzheimer's disease	3.57e-06	2.8e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—GSK3B—Alzheimer's disease	3.56e-06	2.79e-05	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—AKT1—Alzheimer's disease	3.56e-06	2.79e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	3.54e-06	2.78e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CAV1—Alzheimer's disease	3.54e-06	2.78e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CREB1—Alzheimer's disease	3.53e-06	2.77e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—INS—Alzheimer's disease	3.51e-06	2.75e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CHAT—Alzheimer's disease	3.51e-06	2.75e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—TPI1—Alzheimer's disease	3.51e-06	2.75e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PPARG—Alzheimer's disease	3.47e-06	2.72e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	3.47e-06	2.72e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—LPL—Alzheimer's disease	3.45e-06	2.71e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCL2—Alzheimer's disease	3.45e-06	2.71e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTGS1—Alzheimer's disease	3.45e-06	2.71e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ENO1—Alzheimer's disease	3.45e-06	2.71e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PPARGC1A—Alzheimer's disease	3.45e-06	2.71e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—AKT1—Alzheimer's disease	3.45e-06	2.71e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—TGFB1—Alzheimer's disease	3.44e-06	2.7e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—HMOX1—Alzheimer's disease	3.44e-06	2.7e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—INS—Alzheimer's disease	3.4e-06	2.67e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IGF1—Alzheimer's disease	3.39e-06	2.66e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CYP2D6—Alzheimer's disease	3.39e-06	2.66e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PTGS2—Alzheimer's disease	3.37e-06	2.64e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—MAOB—Alzheimer's disease	3.36e-06	2.64e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ND1—Alzheimer's disease	3.35e-06	2.63e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NOS2—Alzheimer's disease	3.33e-06	2.61e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PPARG—Alzheimer's disease	3.33e-06	2.61e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—TPI1—Alzheimer's disease	3.3e-06	2.59e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CHAT—Alzheimer's disease	3.3e-06	2.59e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NOTCH1—Alzheimer's disease	3.3e-06	2.59e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IL6—Alzheimer's disease	3.28e-06	2.57e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—INS—Alzheimer's disease	3.26e-06	2.56e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GAPDH—Alzheimer's disease	3.23e-06	2.54e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—MTHFR—Alzheimer's disease	3.22e-06	2.52e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—BCHE—Alzheimer's disease	3.21e-06	2.52e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—MAOB—Alzheimer's disease	3.17e-06	2.49e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—LPL—Alzheimer's disease	3.14e-06	2.47e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—A2M—Alzheimer's disease	3.12e-06	2.45e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	3.12e-06	2.45e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—MTHFR—Alzheimer's disease	3.11e-06	2.44e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—GSK3B—Alzheimer's disease	3.1e-06	2.43e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CASP3—Alzheimer's disease	3.09e-06	2.43e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CREB1—Alzheimer's disease	3.07e-06	2.41e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—INS—Alzheimer's disease	3.05e-06	2.4e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	3.05e-06	2.39e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PLCB1—Alzheimer's disease	3.03e-06	2.38e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—AKT1—Alzheimer's disease	3.02e-06	2.37e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CALM1—Alzheimer's disease	3e-06	2.36e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—APOE—Alzheimer's disease	2.99e-06	2.35e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—NOS3—Alzheimer's disease	2.99e-06	2.34e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CAV1—Alzheimer's disease	2.97e-06	2.33e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—A2M—Alzheimer's disease	2.94e-06	2.31e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ABCA1—Alzheimer's disease	2.94e-06	2.3e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—TGFB1—Alzheimer's disease	2.91e-06	2.28e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CALM1—Alzheimer's disease	2.91e-06	2.28e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—APOE—Alzheimer's disease	2.9e-06	2.27e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CAV1—Alzheimer's disease	2.87e-06	2.25e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—NOS3—Alzheimer's disease	2.86e-06	2.25e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MAPK8—Alzheimer's disease	2.84e-06	2.23e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—MTHFR—Alzheimer's disease	2.83e-06	2.22e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—IL6—Alzheimer's disease	2.82e-06	2.21e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PTGS2—Alzheimer's disease	2.73e-06	2.14e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ACHE—Alzheimer's disease	2.72e-06	2.13e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—INPP5D—Alzheimer's disease	2.69e-06	2.11e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NOS3—Alzheimer's disease	2.68e-06	2.1e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CALM1—Alzheimer's disease	2.64e-06	2.08e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	2.64e-06	2.07e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—APOE—Alzheimer's disease	2.63e-06	2.07e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—VEGFA—Alzheimer's disease	2.62e-06	2.06e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PTGS2—Alzheimer's disease	2.62e-06	2.05e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CASP3—Alzheimer's disease	2.61e-06	2.05e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CAV1—Alzheimer's disease	2.61e-06	2.05e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PPARG—Alzheimer's disease	2.61e-06	2.05e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—AKT1—Alzheimer's disease	2.6e-06	2.04e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—IL6—Alzheimer's disease	2.59e-06	2.03e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ACHE—Alzheimer's disease	2.56e-06	2.01e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—INS—Alzheimer's disease	2.56e-06	2.01e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ENO1—Alzheimer's disease	2.55e-06	2e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTGS1—Alzheimer's disease	2.55e-06	2e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	2.53e-06	1.99e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PPARGC1A—Alzheimer's disease	2.53e-06	1.99e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PPARG—Alzheimer's disease	2.52e-06	1.98e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—HMOX1—Alzheimer's disease	2.52e-06	1.98e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	2.5e-06	1.96e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—INS—Alzheimer's disease	2.47e-06	1.94e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PTGS2—Alzheimer's disease	2.45e-06	1.92e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TGFB1—Alzheimer's disease	2.41e-06	1.89e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MAPK8—Alzheimer's disease	2.4e-06	1.89e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ENO1—Alzheimer's disease	2.4e-06	1.88e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	2.4e-06	1.88e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—AKT1—Alzheimer's disease	2.39e-06	1.88e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—BCHE—Alzheimer's disease	2.37e-06	1.86e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—LPL—Alzheimer's disease	2.3e-06	1.81e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PPARG—Alzheimer's disease	2.29e-06	1.8e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—INS—Alzheimer's disease	2.25e-06	1.77e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—NOS3—Alzheimer's disease	2.24e-06	1.76e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PLCB1—Alzheimer's disease	2.23e-06	1.75e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—BCHE—Alzheimer's disease	2.23e-06	1.75e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—VEGFA—Alzheimer's disease	2.22e-06	1.74e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—IL6—Alzheimer's disease	2.19e-06	1.72e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—NOS3—Alzheimer's disease	2.17e-06	1.7e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ABCA1—Alzheimer's disease	2.17e-06	1.7e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CHAT—Alzheimer's disease	2.16e-06	1.7e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—TPI1—Alzheimer's disease	2.16e-06	1.7e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	2.11e-06	1.65e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—AKT1—Alzheimer's disease	2.08e-06	1.63e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—MTHFR—Alzheimer's disease	2.07e-06	1.63e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—MAOB—Alzheimer's disease	2.07e-06	1.63e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PTGS2—Alzheimer's disease	2.05e-06	1.61e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	2.04e-06	1.6e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TGFB1—Alzheimer's disease	2.04e-06	1.6e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—AKT1—Alzheimer's disease	2.02e-06	1.59e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—AKT1—Alzheimer's disease	2e-06	1.57e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.99e-06	1.56e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PTGS2—Alzheimer's disease	1.98e-06	1.56e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TP53—Alzheimer's disease	1.98e-06	1.56e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—NOS3—Alzheimer's disease	1.97e-06	1.55e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CALM1—Alzheimer's disease	1.94e-06	1.52e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—APOE—Alzheimer's disease	1.93e-06	1.52e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.92e-06	1.51e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CAV1—Alzheimer's disease	1.91e-06	1.5e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	1.87e-06	1.46e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—AKT1—Alzheimer's disease	1.86e-06	1.46e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—HMOX1—Alzheimer's disease	1.86e-06	1.46e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL6—Alzheimer's disease	1.82e-06	1.42e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PTGS2—Alzheimer's disease	1.81e-06	1.42e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—TGFB1—Alzheimer's disease	1.77e-06	1.39e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	1.76e-06	1.38e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	1.75e-06	1.37e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—LPL—Alzheimer's disease	1.7e-06	1.33e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—AKT1—Alzheimer's disease	1.69e-06	1.33e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PPARG—Alzheimer's disease	1.68e-06	1.32e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TP53—Alzheimer's disease	1.68e-06	1.32e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.67e-06	1.31e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—AKT1—Alzheimer's disease	1.67e-06	1.31e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.66e-06	1.3e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—INS—Alzheimer's disease	1.65e-06	1.29e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—LPL—Alzheimer's disease	1.6e-06	1.26e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.57e-06	1.23e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.57e-06	1.23e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.54e-06	1.21e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL6—Alzheimer's disease	1.53e-06	1.2e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—MTHFR—Alzheimer's disease	1.53e-06	1.2e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.46e-06	1.14e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—NOS3—Alzheimer's disease	1.45e-06	1.14e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	1.44e-06	1.13e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CALM1—Alzheimer's disease	1.43e-06	1.12e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—APOE—Alzheimer's disease	1.42e-06	1.12e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—AKT1—Alzheimer's disease	1.41e-06	1.11e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CAV1—Alzheimer's disease	1.41e-06	1.11e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.38e-06	1.08e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—AKT1—Alzheimer's disease	1.37e-06	1.08e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CALM1—Alzheimer's disease	1.35e-06	1.06e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—APOE—Alzheimer's disease	1.34e-06	1.05e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—IL6—Alzheimer's disease	1.33e-06	1.05e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.33e-06	1.05e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CAV1—Alzheimer's disease	1.33e-06	1.04e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PTGS2—Alzheimer's disease	1.32e-06	1.04e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—AKT1—Alzheimer's disease	1.32e-06	1.03e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PPARG—Alzheimer's disease	1.24e-06	9.74e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—AKT1—Alzheimer's disease	1.23e-06	9.66e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—INS—Alzheimer's disease	1.22e-06	9.55e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PPARG—Alzheimer's disease	1.17e-06	9.18e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.15e-06	9.03e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—INS—Alzheimer's disease	1.15e-06	9e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.14e-06	8.98e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—NOS3—Alzheimer's disease	1.07e-06	8.38e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.05e-06	8.22e-06	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—AKT1—Alzheimer's disease	1.03e-06	8.09e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.01e-06	7.89e-06	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—AKT1—Alzheimer's disease	9.97e-07	7.83e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PTGS2—Alzheimer's disease	9.76e-07	7.66e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	9.43e-07	7.4e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	9.2e-07	7.22e-06	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—AKT1—Alzheimer's disease	9.07e-07	7.12e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CALM1—Alzheimer's disease	8.81e-07	6.91e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—APOE—Alzheimer's disease	8.78e-07	6.89e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CAV1—Alzheimer's disease	8.69e-07	6.82e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PPARG—Alzheimer's disease	7.64e-07	6e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—INS—Alzheimer's disease	7.5e-07	5.88e-06	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—AKT1—Alzheimer's disease	6.65e-07	5.22e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NOS3—Alzheimer's disease	6.57e-07	5.16e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	6.01e-07	4.72e-06	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—AKT1—Alzheimer's disease	4.91e-07	3.85e-06	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—AKT1—Alzheimer's disease	4.62e-07	3.63e-06	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—AKT1—Alzheimer's disease	3.02e-07	2.37e-06	CbGpPWpGaD
